// App-Quantinova.ai

983 : Response Adapted Therapy in ETV6/RUNX1-Positive Childhood Acute Lymphoblastic Leukemia Treated per Modified St Jude Total XV Study

Researchers

Presenter

  • Mayada Abu Shanap

Principal Investigators

  • Iyad Sultan

  • Amal Abu-Ghosh

  • Hasan Hashem

  • Abdelghani Tbakhi

  • Rawad Rihani

Medical Centers

  • Pediatric Department, King Hussein Cancer center (KHCC), Amman, Jordan

  • Pediatric Department, King Hussein Cancer center (KHCC), Amman, Jordan

  • Pediatric Department, King Hussein Cancer center (KHCC), Amman, Jordan

  • Department of Pediatrics, King Hussein Cancer Center, Amman, OH, Jordan

  • Department of Cell Therapy and Applied Genomics, King Hussein Cancer Center, Aurora, Canada

Locations

  • Jordan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • ETV6-RUNX1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved